High-resolution 500 MHz solution-state 1H
and 13C NMR spectra of various
poly(lactides)
indicate at least hexad stereosequence sensitivity. The
poly(lactides) were prepared in vials by melt
polymerization of various combinations of l-lactide,
d-lactide, and meso-lactide at 180 °C for 3 h
using
tin(II) bis(2-ethylhexanoate) (tin(II) octoate) as the
catalyst in a 1:10 000 ratio. The intensity
distribution
of the various stereosequence resonances in the NMR spectra indicates a
preference for syndiotactic
addition during the polymerization process. Minimal evidence of
transesterification was observed for
these polymerization conditions.
Solid-state 13 C CP-MAS NMR spectroscopy has been used to investigate highly crystalline, partially crystalline, and amorphous poly(L-lactide) (PLLA). The amorphous domains have broad resonances with Gaussian line shapes, while the crystalline domains have narrower resonances with a high degree of Lorentzian character. Spectra of highly crystalline PLLA have at least five distinct resonances for the carbonyl and methine functional groups in the polymer, indicating five or more crystallographically inequivalent sites in the crystalline domains of the polymer. For the amorphous polymer, broad Gaussian peaks are observed for each of the methyl, methine, and carbonyl functional groups. Spectra of partially crystalline PLLA contains spectral features of both domains, and furthermore, the spectra appear to be sensitive to both short range (nanometer) and long range (micrometer) order within the polymer. A method to extract the information of crystallinity and morphology from the solidstate CP-MAS NMR spectra of partially crystalline PLLA is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.